Which funds bought or sold ALAB in Q3 2026?
Astera Labs Inc. 13 funds bought, 5 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$3.9B.
Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)
- BlackRock+$560M
- Millennium+$341M
- Amundi+$308M
- Two Sigma+$211M
- Vanguard+$207M
- Baillie Gifford+$202M
- QRT+$183M
- Renaissance+$149M
- Marshall Wace+$120M
- Vanguard Capital+$103M
- Fidelity−$3.2B
- Whale RockOUT−$757M
- Maverick−$379M
- Tudor−$64M
- Light Street−$1M
Top 10 each side. NEW = opened a position, OUT = sold the whole position.
Bought (13)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| BlackRock Index giant | Added+11.5% | +$560M | $5.4B |
| Millennium Quant & multi-strategy | Added+158.4% | +$341M | $556M |
| Amundi Asset manager | Added+54.4% | +$308M | $875M |
| Two Sigma Quant & multi-strategy | Added+1232.5% | +$211M | $228M |
| Vanguard Index giant | Added+7.4% | +$207M | $3.0B |
| Baillie Gifford Growth / crossover | Added+260.2% | +$202M | $280M |
| QRT Quant & multi-strategy | Added+165% | +$183M | $294M |
| Renaissance Quant & multi-strategy | Added+272.1% | +$149M | $203M |
| Marshall Wace Quant & multi-strategy | Added+819.7% | +$120M | $134M |
| Vanguard Capital Index giant | Added+4.3% | +$103M | $2.5B |
| Geode Index giant | Added+8.4% | +$83M | $1.1B |
| Susquehanna Quant & multi-strategy | Added+79.5% | +$77M | $174M |
| ExodusPoint Quant & multi-strategy | New | +$46M | $46M |
Sold (5)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Fidelity Asset manager | Trimmed-36.5% | −$3.2B | $5.6B |
| Whale Rock Growth / crossover | Sold out | −$757M | — |
| Maverick Hedge fund | Trimmed-99.7% | −$379M | $1M |
| Tudor Hedge fund | Trimmed-50% | −$64M | $64M |
| Light Street Growth / crossover | Trimmed-2.8% | −$1M | $44M |
Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.